Albemarle Corp sell Morgan Stanley
Start price
18.02.25
/
50%
€80.00
Target price
18.02.26
€65.06
Performance (%)
-17.46%
Price
20:27
€66.03
Summary
This prediction is currently active. The price of Albemarle Corp has decreased since the start of the prediction. Compared to the start price this results in a performance of -17.46%. This prediction currently runs until 18.02.26. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionAlbemarle is a specialty chemical company that produces and markets lithium, bromine, and other specialty chemicals globally. The company's products are used in a wide range of applications, including energy storage, flame retardants, pharmaceuticals, and agricultural solutions. Albemarle's lithium business has been a key driver of growth in recent years due to increasing demand for lithium-ion batteries used in electric vehicles and other technologies. The company has a market capitalization of around $11 billion and is listed on the New York Stock Exchange under the ticker symbol ALB.
Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Albemarle Corp | 0.199% | 0.199% |
| iShares Core DAX® | -1.691% | 2.604% |
| iShares Nasdaq 100 | 0.913% | 3.716% |
| iShares Nikkei 225® | -2.346% | -1.208% |
| iShares S&P 500 | 0.732% | 3.130% |
Comments by Morgan_Stanley for this prediction
In the thread Albemarle Corp diskutieren
Albemarle Co. (NYSE: ALB) had its price target lowered by analysts at Morgan Stanley from $73.00 to $68.00. They now have an "underweight" rating on the stock.
Ratings data for ALB provided by MarketBeat